Acuvail - (0.45% Solution/Drops; Ophthalmic)

Generic Name	Ketorolac Tromethamine	Innovator	Allergan
Dosage	0.45% Solution/Drops; Ophthalmic	Branded US Sales	Less Than $1000 mn
Probable FTF	Less Than 5	Known Para IV Filers	Less Than 5
Other ANDA developers	None	Tentative Approvals	Less Than 5
Final Approvals	Less Than 5	Generic Launches	Less Than 5
Indication	Used to reduce swelling, pain, and burning or stinging after cataract surgery.
Complexities	Yes

Executive Summary

Patent Status

Launch Timelines and Competition

Company	FTF Status / 180 days exclusivity	30-Months stay	Current Litigation Status	Current Approval Status	Likelihood of launch
*****	*** \ *********	**** **, ****	*******	******** ************	******** ** *** **, ****

Chronology Of Events